Prevalence of depression among people with type 2 diabetes mellitus: a cross sectional study in Palestine

BMC Public Health

Sa’ed H Zyoud¹  Samah W Al-Jabi³  Hanadi M Abu-Hadeed²  Waleed M Sweileh¹ 

[1] Department of Pharmacology/ Toxicology, College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine;Qalqilia Governmental Hospital, Ministry of Health, Qalqilia, Palestine;Department of Clinical and Comunity Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine

关键词: Palestine;    Depression;    Diabetes mellitus;   

Others  :  1145329
DOI  :  10.1186/1471-2458-14-163

 received in 2013-06-28, accepted in 2014-02-11,  发布年份 2014

【 摘 要 】

Background

Diabetes mellitus is a common chronic metabolic disorder and one of the main causes of death in Palestine. Palestinians are continuously living under stressful economic and military conditions which make them psychologically vulnerable. The purpose of this study was to investigate the prevalence of depression among type II diabetic patients and to examine the relationship between depression and socio-demographic factors, clinical factors, and glycemic control.

Methods

This was a cross-sectional study at Al-Makhfiah primary healthcare center, Nablus, Palestine. Two hundred and ninety-four patients were surveyed for the presence of depressive symptoms using Beck Depression Inventory (BDI-II) scale. Patients' records were reviewed to obtain data pertaining to age, sex, marital status, Body Mass Index (BMI), level of education, smoking status, duration of diabetes mellitus, glycemic control using HbA1C test, use of insulin, and presence of additional illnesses. Patients’ medication adherence was assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8).

Results

One hundred and sixty four patients (55.8%) of the total sample were females and 216 (73.5%) were < 65 years old. One hundred and twenty patients (40.2%) scored ≥ 16 on BDI-II scale. Statistical significant association was found between high BDI-II score (≥ 16) and female gender, low educational level, having no current job, having multiple additional illnesses, low medication adherence and obesity (BMI ≥ 30 kg/m2). No significant association between BDI score and glycemic control, duration of diabetes, and other socio-demographic factors was found. Multivatriate analysis showed that low educational level, having no current job, having multiple additional illnesses and low medication adherence were significantly associated with high BDI-II scores.

Conclusion

Prevalence of depression found in our study was higher than that reported in other countries. Although 40% of the screened patients were potential cases of depression, none were being treated with anti-depressants. Psychosocial assessment should be part of routine clinical evaluation of these patients at primary healthcare clinics to improve quality of life and decrease adverse outcomes among diabetic patients.

【 授权许可】

   
2014 Sweileh et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Shaw JE, Sicree RA, Zimmet PZ: Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87(1):4-14.
• [2]Abdul-Rahim HF, Husseini A, Giacaman R, Jervell J, Bjertness E: Diabetes mellitus in an urban Palestinian population: prevalence and associated factors. East Mediterr Health J 2001, 7(1–2):67-78.
• [3]Husseini A, Abdul-Rahim H, Awartani F, Jervell J, Bjertness E: Prevalence of diabetes mellitus and impaired glucose tolerance in a rural Palestinian population. East Mediterr Health J 2000, 6(5–6):1039-1045.
• [4]Husseini A, Abdul-Rahim H, Awartani F, Giacaman R, Jervell J, Bjertness E: Type 2 diabetes mellitus, impaired glucose tolerance and associated factors in a rural Palestinian village. Diabet Med 2000, 17(10):746-748.
• [5]Husseini A, Abu-Rmeileh NM, Mikki N, Ramahi TM, Ghosh HA, Barghuthi N, Khalili M, Bjertness E, Holmboe-Ottesen G, Jervell J: Cardiovascular diseases, diabetes mellitus, and cancer in the occupied Palestinian territory. Lancet 2009, 373(9668):1041-1049.
• [6]Greden JF: Physical symptoms of depression: unmet needs. J Clin Psychiatry 2003, 64(Suppl 7):5-11.
• [7]Demyttenaere K, Bruffaerts R, Posada-Villa J, Gasquet I, Kovess V, Lepine JP, Angermeyer MC, Bernert S, de Girolamo G, Morosini P, et al.: Prevalence, severity, and unmet need for treatment of mental disorders in the world health organization world mental health surveys. JAMA 2004, 291(21):2581-2590.
• [8]Meyer C: Depressive disorders were the fourth leading cause of global disease burden in the year 2000. Evid Based Ment Health 2004, 7(4):123.
• [9]Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ: Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004, 184:386-392.
• [10]Michaud CM, Murray CJ, Bloom BR: Burden of disease–implications for future research. JAMA 2001, 285(5):535-539.
• [11]Li C, Ford ES, Strine TW, Mokdad AH: Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system. Diabetes Care 2008, 31(1):105-107.
• [12]Ali S, Stone MA, Peters JL, Davies MJ, Khunti K: The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med 2006, 23(11):1165-1173.
• [13]Katon W, Von Korff M, Ciechanowski P, Russo J, Lin E, Simon G, Ludman E, Walker E, Bush T, Young B: Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 2004, 27(4):914-920.
• [14]Katon WJ, Simon G, Russo J, Von Korff M, Lin EHB, Ludman E, Ciechanowski P, Bush T: Quality of depression care in a population-based sample of patients with diabetes and major depression. Med Care 2004, 42(12):1222-1229.
• [15]Giacaman R, Khatib R, Shabaneh L, Ramlawi A, Sabri B, Sabatinelli G, Khawaja M, Laurance T: Health status and health services in the occupied Palestinian territory. Lancet 2009, 373(9666):837-849.
• [16]Palestinian Ministry of Health: Health Status in Palestine 2011. 2011. http://www.moh.ps/attach/441.pdf webcite. Accessed 30 January 2013
• [17]Al-Amer RM, Sobeh MM, Zayed AA, Al-Domi HA: Depression among adults with diabetes in Jordan: risk factors and relationship to blood sugar control. J Diabetes Complications 2011, 25(4):247-252.
• [18]Beck AT, Steer RA, Brown GK: Manual for Beck Depression lnventory-II. San Antonio, TX: Psychological Corporation; 1996.
• [19]Beck AT, Guth D, Steer RA, Ball R: Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther 1997, 35(8):785-791.
• [20]Steer RA, Ball R, Ranieri WF, Beck AT: Further evidence for the construct validity of the Beck depression Inventory-II with psychiatric outpatients. Psychol Rep 1997, 80(2):443-446.
• [21]Steer RA, Ball R, Ranieri WF, Beck AT: Dimensions of the Beck Depression Inventory-II in clinically depressed outpatients. J Clin Psychol 1999, 55(1):117-128.
• [22]Steer RA, Cavalieri TA, Leonard DM, Beck AT: Use of the Beck Depression Inventory for Primary Care to screen for major depression disorders. Gen Hosp Psychiatry 1999, 21(2):106-111.
• [23]Steer RA, Clark DA, Beck AT, Ranieri WF: Common and specific dimensions of self-reported anxiety and depression: the BDI-II versus the BDI-IA. Behav Res Ther 1999, 37(2):183-190.
• [24]Steer RA, Rissmiller DJ, Beck AT: Use of the beck depression inventory-II with depressed geriatric inpatients. Behav Res Ther 2000, 38(3):311-318.
• [25]Winter LB, Steer RA, Jones-Hicks L, Beck AT: Screening for major depression disorders in adolescent medical outpatients with the beck depression inventory for primary care. J Adolesc Health 1999, 24(6):389-394.
• [26]Alansari BM: Beck Depression Inventory (BDI-II) items characteristics among undergraduate students of nineteen Islamic countries. Soc Behav Pers 2005, 33(7):675-684.
• [27]Alansari BM: Gender differences in depression among undergraduates from seventeen Islamic countries. Soc Behav Person 2006, 34(6):729-738.
• [28]Lustman PJ, Clouse RE, Griffith LS, Carney RM, Freedland KE: Screening for depression in diabetes using the beck depression inventory. Psychosom Med 1997, 59(1):24-31.
• [29]American Diabetes Association: Standards of medical care in diabetes--2010. Diabetes Care 2010, 33 Suppl 1:S11-61.
• [30]Morisky DE, Green LW, Levine DM: Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24(1):67-74.
• [31]Jamous RM, Sweileh WM, Abu-Taha AS, Sawalha AF, Zyoud SH, Morisky DE: Adherence and satisfaction with oral hypoglycemic medications: a pilot study in Palestine. Int J Clin Pharm 2011, 33(6):942-948.
• [32]Pibernik-Okanovic M, Peros K, Szabo S, Begic D, Metelko Z: Depression in Croatian Type 2 diabetic patients: prevalence and risk factors. A Croatian survey from the European Depression in Diabetes (EDID) Research Consortium. Diabet Med 2005, 22(7):942-945.
• [33]Chou KL, Chi I: Prevalence of depression among elderly Chinese with diabetes. Int J Geriatr Psychiatry 2005, 20(6):570-575.
• [34]Ali S, Davies MJ, Taub NA, Stone MA, Khunti K: Prevalence of diagnosed depression in South Asian and white European people with type 1 and type 2 diabetes mellitus in a UK secondary care population. Postgrad Med J 2009, 85(1003):238-243.
• [35]Asghar S, Hussain A, Ali SM, Khan AK, Magnusson A: Prevalence of depression and diabetes: a population-based study from rural Bangladesh. Diabet Med 2007, 24(8):872-877.
• [36]Pouwer F, Geelhoed-Duijvestijn PH, Tack CJ, Bazelmans E, Beekman AJ, Heine RJ, Snoek FJ: Prevalence of comorbid depression is high in out-patients with Type 1 or Type 2 diabetes mellitus. Results from three out-patient clinics in the Netherlands. Diabet Med 2010, 27(2):217-224.
• [37]Engum A, Mykletun A, Midthjell K, Holen A, Dahl AA: Depression and diabetes: a large population-based study of sociodemographic, lifestyle, and clinical factors associated with depression in type 1 and type 2 diabetes. Diabetes Care 2005, 28(8):1904-1909.
• [38]Mezuk B, Eaton WW, Albrecht S, Golden SH: Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008, 31(12):2383-2390.
• [39]Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001, 24(6):1069-1078.
• [40]Zahid N, Asghar S, Claussen B, Hussain A: Depression and diabetes in a rural community in Pakistan. Diabetes Res Clin Pract 2008, 79(1):124-127.
• [41]Lloyd CE, Dyer PH, Barnett AH: Prevalence of symptoms of depression and anxiety in a diabetes clinic population. Diabet Med 2000, 17(3):198-202.
• [42]Bailey BJ: Mediators of depression in adults with diabetes. Clin Nurs Res 1996, 5(1):28-42.
• [43]Rubin RT, Poland RE, Lesser IM, Winston RA, Blodgett AL: Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls. Arch Gen Psychiatry 1987, 44(4):328-336.
• [44]Grisel JE, Rasmussen PR, Sperry L: Anxiety and depression: physiological and pharmacological considerations. J Individ Psychol 2006, 62(4):398-416.
• [45]Lustman PJ, Clouse RE: Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 2005, 19(2):113-122.
• [46]Katon WJ: The comorbidity of diabetes mellitus and depression. Am J Med 2008, 121(11 Suppl 2):S8-15.
• [47]Ciechanowski PS, Katon WJ, Russo JE: Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000, 160(21):3278-3285.
• [48]Katon WJ, Rutter C, Simon G, Lin EH, Ludman E, Ciechanowski P, Kinder L, Young B, Von Korff M: The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005, 28(11):2668-2672.
• [49]Sahota PKC, Knowler WC, Looker HC: Depression, diabetes, and glycemic control in an American Indian community. J Clin Psychiatry 2008, 69(5):800-809.
• [50]Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE: Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000, 23(7):934-942.
• [51]Wagner JA, Abbott GL, Heapy A, Yong L: Depressive symptoms and diabetes control in African Americans. J Immigr Minor Health 2009, 11(1):66-70.
• [52]Dirmaier J, Watzke B, Koch U, Schulz H, Lehnert H, Pieper L, Wittchen HU: Diabetes in primary care: prospective associations between depression, nonadherence and glycemic control. Psychother Psychosom 2010, 79(3):172-178.
• [53]De Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ: Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001, 63(4):619-630.
• [54]Egede LE: Effect of comorbid chronic diseases on prevalence and odds of depression in adults with diabetes. Psychosom Med 2005, 67(1):46-51.
• [55]Black SA, Markides KS, Ray LA: Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care 2003, 26(10):2822-2828.
• [56]Winocour PH, Main CJ, Medlicott G, Anderson DC: A psychometric evaluation of adult patients with type 1 (insulin-dependent) diabetes mellitus: prevalence of psychological dysfunction and relationship to demographic variables, metabolic control and complications. Diabetes Res 1990, 14(4):171-176.
• [57]Viinamaki H, Niskanen L, Uusitupa M: Mental well-being in people with non-insulin-dependent diabetes. Acta Psychiatr Scand 1995, 92(5):392-397.
• [58]Peyrot M, Rubin RR: Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care 1997, 20(4):585-590.
• [59]Surwit RS, van Tilburg MA, Parekh PI, Lane JD, Feinglos MN: Treatment regimen determines the relationship between depression and glycemic control. Diabetes Res Clin Pract 2005, 69(1):78-80.
• [60]Van Tilburg MA, McCaskill CC, Lane JD, Edwards CL, Bethel A, Feinglos MN, Surwit RS: Depressed mood is a factor in glycemic control in type 1 diabetes. Psychosom Med 2001, 63(4):551-555.
• [61]Ciechanowski PS, Katon WJ, Russo JE, Hirsch IB: The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen Hosp Psychiatry 2003, 25(4):246-252.
• [62]de Groot M, Jacobson AM, Samson JA, Welch G: Glycemic control and major depression in patients with type 1 and type 2 diabetes mellitus. J Psychosom Res 1999, 46(5):425-435.
• [63]Georgiades A, Zucker N, Friedman KE, Mosunic CJ, Applegate K, Lane JD, Feinglos MN, Surwit RS: Changes in depressive symptoms and glycemic control in diabetes mellitus. Psychosom Med 2007, 69(3):235-241.
• [64]de Groot M, Doyle T, Hockman E, Wheeler C, Pinkerman B, Shubrook J, Gotfried R, Schwartz F: Depression among type 2 diabetes rural Appalachian clinic attendees. Diabetes Care 2007, 30(6):1602-1604.
• [65]de Groot M, Pinkerman B, Wagner J, Hockman E: Depression treatment and satisfaction in a multicultural sample of type 1 and type 2 diabetic patients. Diabetes Care 2006, 29(3):549-553.
• [66]Nichols GA, Brown JB: Unadjusted and adjusted prevalence of diagnosed depression in type 2 diabetes. Diabetes Care 2003, 26(3):744-749.
• [67]Sacco WP, Wells KJ, Friedman A, Matthew R, Perez S, Vaughan CA: Adherence, body mass index, and depression in adults with type 2 diabetes: the mediational role of diabetes symptoms and self-efficacy. Health Psychol 2007, 26(6):693-700.
• [68]Lerman I, Lozano L, Villa AR, Hernandez-Jimenez S, Weinger K, Caballero AE, Salinas CA, Velasco ML, Gomez-Perez FJ, Rull JA: Psychosocial factors associated with poor diabetes self-care management in a specialized center in Mexico City. Biomed Pharmacother 2004, 58(10):566-570.
• [69]Park H, Hong Y, Lee H, Ha E, Sung Y: Individuals with type 2 diabetes and depressive symptoms exhibited lower adherence with self-care. J Clin Epidemiol 2004, 57(9):978-984.
• [70]Finkelstein EA, Bray JW, Chen H, Larson MJ, Miller K, Tompkins C, Keme A, Manderscheid R: Prevalence and costs of major depression among elderly claimants with diabetes. Diabetes Care 2003, 26(2):415-420.
• [71]McCollum M, Ellis SL, Regensteiner JG, Zhang W, Sullivan PW: Minor depression and health status among US adults with diabetes mellitus. Am J Manag Care 2007, 13(2):65-72.
• [72]Brown GC, Brown MM, Sharma S, Brown H, Gozum M, Denton P: Quality of life associated with diabetes mellitus in an adult population. J Diabetes Complications 2000, 14(1):18-24.
• [73]Egede LE: Diabetes, major depression, and functional disability among US adults. Diabetes Care 2004, 27(2):421-428.
• [74]Egede LE: Effect of depression on self-management behaviors and health outcomes in adults with type 2 diabetes. Curr Diabetes Rev 2005, 1(3):235-243.
• [75]Gonzalez JS, Safren SA, Delahanty LM, Cagliero E, Wexler DJ, Meigs JB, Grant RW: Symptoms of depression prospectively predict poorer self-care in patients with Type 2 diabetes. Diabet Med 2008, 25(9):1102-1107.
• [76]Blazer DG, Moody-Ayers S, Craft-Morgan J, Burchett B: Depression in diabetes and obesity: racial/ethnic/gender issues in older adults. J Psychosom Res 2002, 53(4):913-916.
• [77]Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Barnes CS: Clinical inertia. Ann Intern Med 2001, 135(9):825-834.
• [78]Karlson B, Agardh CD: Burden of illness, metabolic control, and complications in relation to depressive symptoms in IDDM patients. Diabet Med 1997, 14(12):1066-1072.
• [79]Miyaoka Y, Miyaoka H, Motomiya T, Kitamura S, Asai M: Impact of sociodemographic and diabetes-related characteristics on depressive state among non-insulin-dependent diabetic patients. Psychiatry Clin Neurosci 1997, 51(4):203-206.
• [80]Palinkas LA, Barrett-Connor E, Wingard DL: Type 2 diabetes and depressive symptoms in older adults: a population-based study. Diabet Med 1991, 8(6):532-539.
• [81]Tsai L-Y, Tsai S-M, Lin M-N, Liu S-F: Effect of hemoglobin variants (Hb J, Hb G, and Hb E) on HbA1c values as measured by cation-exchange HPLC (Diamat). Clin Chem 2001, 47(4):756-758.
• [82]Nasir NM, Thevarajah M, Yean CY: Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements. Int J Diabetes Dev Ctries 2010, 30(2):86-90.